natgillin/translations-raw huggingface dataset:
In these studies treatment with BRINAVESS effectively converted atrial fibrillation to sinus rhythm as compared with placebo (see Table 2).
V teh študijah je zdravilo BRINAVESS učinkovito doseglo prehod iz atrijske fibrilacije v sinusni ritem v primerjavi s placebom (glejte preglednico 2).
In these studies, 155 patients (59 antiretroviral-naive and 96 antiretroviral-experienced) received once daily REYATAZ oral powder and ritonavir, in combination with two NRTIs.
V teh študijah je 155 bolnikov (59 bolnikov se predhodno še ni zdravilo s protiretrovirusnimi zdravili, 96 bolnikov pa se je predhodno že zdravilo s protiretrovirusnimi zdravili) prejemalo zdravilo REYATAZ v obliki peroralnega praška enkrat na dan in ritonavir v kombinaciji z dvema NRTI-jema.
In these studies, Avastin, in combination with carboplatin and paclitaxel, was compared with carboplatin and paclitaxel alone.
V teh študijah so zdravilo Avastin v kombinaciji s karboplatinom in paklitakselom primerjali s karboplatinom in paklitakselom kot samostojnima zdraviloma.
In these studies, individuals who were seronegative for anti-HPV 6, anti-HPV 11, anti-HPV 16, and anti-HPV 18 in the cLIA were still protected against clinical disease after a follow-up of 9 years for 16-23 year-old women, 8 years for 24-45 year-old women, and 6 years for 16-26 year-old men.
V teh študijah so bile po 9-letnem spremljanju žensk, starih od 16 do 23 let, 8-letnem spremljanju žensk, starih od 24 do 45 let in 6-letnem spremljanju moških, starih od 16 do 26 let, osebe, ki so bile po metodi cLIA seronegativne za anti-HPV 6, anti-HPV 11, anti-HPV 16 in anti-HPV 18, še vedno zaščitene pred klinično boleznijo.
In these studies, myelofibrosis was not observed in animals after a 4-week post- treatment recovery period, indicating reversibility.
V teh študijah po koncu 4-tedenskega okrevanja po zdravljenju pri živalih niso ugotovili mielofibroze, kar nakazuje reverzibilnost.
In these studies, Perjeta was given with trastuzumab and/or chemotherapy.
V navedenih študijah so zdravilo Perjeta dajali skupaj s trastuzumabom in/ali kemoterapijo.
In these studies, SonoVue was not compared with any other medicine, but the results of the test with SonoVue were compared with the ‘gold standard’, such as angiography (X-rays of blood vessels).
V teh študijah zdravila SonoVue niso primerjali z nobenim drugim zdravilom, vendar so rezultate preizkusa s tem zdravilom primerjali z zlatim standardom, kot je na primer angiografija (rentgensko slikanje krvnih žil).
In these studies, study medication was initiated the day prior to surgery, continued on the day of surgery and for up to 90 days of the postoperative period.
V teh študijah so začeli z dajanjem proučevanega zdravila dan pred operacijo ter z njim nadaljevali na dan operacije in še do 90 dni pooperativnega obdobja.
In these studies, Tasigna was not compared with any other treatment.
V teh študijah zdravila Tasigna niso primerjali z nobenim drugim zdravilom.
In these studies, the estimated 1-year survival rates were 59.2% (95% CI: 53.0 - 64.8) and 46.7% (95% CI: 38.1 - 54.9).
Ocenjeni delež 1-letnega preživetja je znašal 59,2 % (95 % interval zaupanja: 53,0 - 64,8) oziroma 46,7 % (95 % interval zaupanja: 38,1 - 54,9).
In these studies, the incidence of other types of arthritis-related adverse events were similar between the Raptiva and placebo groups.
V teh študijah je bila incidenca neželenih dogodkov povezanih z drugimi tipi artritisa podobna v skupini z Raptivo in skupini s placebom.
In these studies, the median age was 68 years (range 21-100); 51 % were females.
V teh študijah je bila mediana starost 68 let (razpon 21-- 100); 51 % je bilo žensk.
In these studies, the percentage of patients taking Pelzont, nicotinic acid (pooled prolonged-release formulations) or pooled placebo/simvastatin who discontinued due to any flushing-related symptom (redness, warmth, itching and tingling) was 7.2 %, 16.6 %, and 0.4 %, respectively.
Zaradi kateregakoli od simptomov zardevanja (rdečica, toplota, srbenje in mravljinčenje) je zdravilo Pelzont v teh študijah nehalo jemati 7,2 % bolnikov, nikotinsko kislino (skupno vse pripravke s podaljšanim delovanjem) 16,6 % bolnikov in placebo/simvastatin 0,4 % bolnikov.
In these studies, the study medicine was added to patients’ current therapy, which could have included a combination of digoxin, anticoagulants, diuretics, oxygen, and vasodilators (eg, calcium channel blockers, ACE inhibitors).
V omenjenih raziskavah so preučevano zdravilo dodali bolnikovi obstoječi terapiji, ki je lahko vključevala kombinacijo digoksina, antikoagulacijskih sredstev, diuretikov, kisika in vazodilatorjev (npr. antagoniste kalcijevih kanalčkov, zaviralce ACE).
In these studies, there were no apparent differences in the pharmacokinetics of topotecan among children, adolescents, and young adult patients with solid tumours or leukaemia, but data are too limited to draw definite conclusions.
V teh študijah ni bilo očitnih razlik v farmakokinetiki topotekana med otroci, mladostniki in mlajšimi odraslimi s solidnimi tumorji ali levkemijo, vendar so podatki preveč omejeni, da bi lahko podali dokončen sklep.
In these study populations, mean additional reductions of supine blood pressure of 7/7 mmHg,
V teh študijskih populacijah so opažali povprečno dodatno znižanje krvnega tlaka leže za 7/7 mmHg, 9/5 mmHg in
In these trials the ovulation rate per cycle was 70-75 %.
V teh preskušanjih je bila stopnja ovulacije na ciklus 70–75 %.
In these trials, 11.9% of patients treated with Trudexa and 8.1% of placebo and active control−treated patients that had negative baseline anti-nuclear antibody titres reported positive titres at week 24.
V teh preskušanjih so pozitivne titre protijedrnih protiteles po 24 tednih ugotovili pri 11,9% prejemnikov Trudexe in 8,1% prejemnikov placeba in kontrolne učinkovine, ki so imeli izhodiščno negativne titre teh protiteles.
In these trials, patients were initially required to be stable on the lowest effective dose of anti Parkinsonian medicinal products (dopamine agonist) and to remain on the same anti-Parkinsonian medicinal products and dosages throughout the study.
V teh preskušanjih je bilo potrebno, da se je zdravstveno stanje bolnikov najprej ustalilo ob prejemanju najnižjega učinkovitega odmerka antiparkinsonskih zdravil (dopaminskih agonistov) ter da so ves čas študije prejemali ista antiparkinsonska zdravila v enakih odmerkih.
In these trials, patients were initially required to be stable on the lowest effective dose of anti- Parkinsonian medicinal products (dopamine agonist) and to remain on the same anti- Parkinsonian medicinal products and dosages throughout the study.
V teh preskušanjih je bilo potrebno, da se je zdravstveno stanje bolnikov najprej ustalilo ob prejemanju najnižjega učinkovitega odmerka antiparkinsonikov (dopaminskih agonistov) ter da so ves čas študije prejemali iste antiparkinsonike v enakih odmerkih.
In these trials, patients were initially required to be stable on the lowest effective dose of anti- Parkinsonian medicinal products (dopamine agonist) and to remain on the same anti-Parkinsonian medicinal products and dosages throughout the study.
V teh preskušanjih je bilo potrebno, da se je zdravstveno stanje bolnikov najprej ustalilo ob prejemanju najnižjega učinkovitega odmerka antiparkinsonikov (dopaminskih agonistov) ter da so ves čas študije prejemali iste antiparkinsonike v enakih odmerkih.
In these trials, patients were initially required to be stable on the lowest effective dose of anti- Parkinsonian medicinal products (dopamine agonist) and to remain on the same anti-Parkinsonian medicinal products and dosages throughout the study.
V teh preskušanjih je bilo potrebno, da se je zdravstveno stanje bolnikov najprej ustalilo ob prejemanju najnižjega učinkovitega odmerka antiparkinsonskih zdravil (dopaminskih agonistov) ter da so ves čas študije prejemali ista antiparkinsonska zdravila v enakih odmerkih.
In these trials, vildagliptin was administered as monotherapy in drug- naïve patients with type 2 diabetes or in combination in patients not adequately controlled by other antidiabetic medicinal products.
V teh preskušanjih so vildagliptin v monoterapiji prejemali bolniki s sladkorno boleznijo tipa 2, ki prej še niso prejemali nobenih zdravil za sladkorno bolezen, v kombinaciji z drugimi zdravili pa tisti bolniki, pri katerih sladkorna bolezen ni bila dovolj dobro urejena z drugimi antidiabetičnimi zdravili.
In this 26-week open label study, 33 MPS I patients received 1 of 4 dose regimens of Aldurazyme: 100 U/kg IV every week (recommended dose), 200 U/kg IV every week, 200 U/kg IV every 2 weeks; or 300 U/kg IV every 2 weeks.
V tej 26-tedenski odprti študiji je 33 bolnikov z MPS I prejemalo 1 izmed 4 režimov odmerjanja: 100 e/kg i.v. vsak teden (priporočeni odmerek), 200 e/kg i.v. vsak teden, 200 e/kg i.v. vsaka 2 tedna ali 300 e/kg i.v. vsaka 2 tedna.
In this 48- week study no unexpected safety findings were observed in either dosing group.
V tej 48-tedenski raziskavi v nobeni od skupin z različnim odmerjanjem niso poročali o nepričakovanih izsledkih, povezanih z varnostjo.
In this 48-week study no unexpected safety findings were observed in either dosing group.
V tej 48-tedenski raziskavi v nobeni od skupin z različnim odmerjanjem niso poročali o nepričakovanih izsledkih, povezanih z varnostjo.
In this 48-week study no unexpected safety findings were observed in either dosing group.
V tej 48-tedenski raziskavi v nobeni od skupin z različnim odmerjanjem niso poročali o nepričakovanih izsledkov, povezanih z varnostjo.
In this active controlled clinical trial, the most common reasons for discontinuation of therapy with Copalia HCT were dizziness and hypotension (0.7%).
V tem aktivno kontroliranem kliničnem preskušanju sta bila najbolj pogosta razloga za prekinitev zdravljenja z zdravilom Copalia HCT omotičnost in hipotenzija (0,7 %).
In this active controlled clinical trial, the most common reasons for discontinuation of therapy with Imprida HCT were dizziness and hypotension (0.7%).
V tem aktivno kontroliranem kliničnem preskušanju sta bila najbolj pogosta razloga za prekinitev zdravljenja z zdravilom Imprida HCT omotičnost in hipotenzija (0,7 %).
In this age group, serotypes 1, 5 and 7F account for 3.3% to 24.1% of IPD depending on the country and time period studied.
Serotipi 1, 5 in 7F povzročijo v tej starostni skupini od 3,3 do 24,1 % invazivne pnevmokokne bolezni, odvisno od države in proučevanega časovnega obdobja.
In this analysis, creatinine clearance was calculated using the Cockcroft-Gault method.
V tej analizi so očistek kreatinina izračunali z Cockcroft-Gaultovo enačbo.
In this analysis, the placebo arm included those patients randomized to placebo who subsequently received open-label sunitinib treatment.
V tej analizi skupina s placebom vključuje tudi tiste randomizirane bolnike s placebom, ki so v odprti študiji naknadno prejeli zdravljenje s sunitinibom.
In this case - you have not received any medicine - even though the dose counter has moved from the original dose that you have set.
V tem primeru niste prejeli nič zdravila, tudi če se je števec odmerka premaknil od začetnega odmerka, ki ste ga nastavili.
In this case close monitoring is required. lopinavir/ritonavir combination (used to treat HIV infection) raltegravir (used to treat HIV infection) telaprevir, boceprevir, simeprevir, daclatasvir (used to treat hepatitis C virus infection) maraviroc (used to treat HIV infection)
V tem primeru je potreben skrben zdravniški nadzor. kombinacija lopinavir/ritonavir (uporabljamo jo za zdravljenje okužbe z virusom HIV) raltegravir (uporabljamo ga za zdravljenje okužbe z virusom HIV) telaprevir, boceprevir, simeprevir, daklatasvir (uporabljamo jih za zdravljenje okužbe z virusom hepatitisa C) maravirok (uporabljamo ga za zdravljenje okužbe z virusom HIV)
In this case close monitoring is required. lopinavir/ritonavir combination (used to treat HIV infection) raltegravir (used to treat HIV infection) telaprevir,boceprevir, simeprevir, daclatasvir (used to treat hepatitis C virus infection) maraviroc (used to treat HIV infection)
V tem primeru je potreben skrben zdravniški nadzor. kombinacija lopinavir/ritonavir (uporabljamo jo za zdravljenje okužbe z virusom HIV) raltegravir (uporabljamo ga za zdravljenje okužbe z virusom HIV) telaprevir, boceprevir, simeprevir, daklatasvir (uporabljamo jih za zdravljenje okužbe z virusom hepatitisa C) maravirok (uporabljamo ga za zdravljenje okužbe z virusom HIV)
In this case dose increases may be necessary.
V tem primeru vam bo morda zdravnik odmerek moral povečati.
In this case immediate administration of a glucose solution and/or food is required.
V tem primeru je potrebna takojšnja uporaba glukozne raztopine in/ali hrane.
In this case infusion sets with minimal priming space should be used (i.e.
V teh primerih je treba uporabiti komplete za infundiranje z najmanjšim možnim lastnim volumnom (tj.
In this case Topotecan Actavis treatment is combined with medicines containing cisplatin.
V tem primeru se zdravilo Topotekan Actavis uporablja skupaj z zdravili, ki vsebujejo cisplatin.
In this case two 15 mg tablets may be taken at once.
V tem primeru lahko vzame dve tableti po 15 mg hkrati.
In this case what should you do: either you can inject what is remaining in the pen and complete your dose with a new OptiSet. or use a new OptiSet for your full dose.
V takšnem primeru lahko: injicirate insulin, ki je še v injekcijskem peresniku, in razliko do celotnega odmerka injicirate z novim OptiSetom, ali uporabite nov OptiSet in z njim injicirate celotni odmerek.
In this case you could also have a higher risk of having a heart attack or stroke;
V tem primeru je morda pri vas tudi večje tveganje za srčni infarkt ali možgansko kap;
In this case you could have a hereditary blood clotting disorder; if you need to have an operation, or if you are off your feet for a long time because of an injury or illness, or you have your leg in a cast.
V takšnem primeru imate morda dedno motnjo strjevanja krvi; če potrebujete kirurški poseg ali če zaradi poškodbe ali bolezni dolgo časa niste na nogah ali če imate nogo v mavcu.
In this case you could have a hereditary blood clotting disorder; if you need to have an operation, or if you are off your feet for a long time because of an injury or illness, or you have your leg in a cast.
V tem primeru imate morda dedno bolezen strjevanja krvi; če morate na kirurški poseg ali če ste dalj časa nepokretni zaradi poškodbe ali bolezni ali če imate nogo v mavcu.
In this case you must change the Insulin Release Unit (IRU) prior to your next inhalation.
V tem primeru morate pred naslednjo inhalacijo nastavek za sproščanje insulina (Insulin release unit - IRU) zamenjati.
In this case you must change the IRU prior to you next inhalation.
V tem primeru morate pred naslednjo inhalacijo nastavek za sproščanje insulina (Insulin release unit - IRU) zamenjati.
In this case you should not take Tybost unless you and your doctor decide it is clearly needed.
V tem primeru ne smete jemati zdravila Tybost, razen če ste se vi in vaš zdravnik odločili, da je to nujno potrebno.
In this case you will get training on how to inject Simponi yourself.
V tem primeru vas bodo poučili, kako naj si sami injicirate zdravilo Simponi.
In this case you will get training on how to inject Stelara yourself.
Navodila za zdravstveno osebje
In this case you will get training on how to inject Stelara yourself.
V tem primeru vas bodo poučili, kako si injicirajte zdravilo Stelara.
In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics
V tem primeru bo zdravnik morda moral redno opravljati krvne preiskave, še posebej tiste, s katerimi bo v primeru slabega delovanja ledvic spremljal vrednosti kalija v krvi. če imate predvideno operacijo (kirurški poseg) ali boste dobili anestetik
In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function,
V tem primeru bo zdravnik morda moral redno opravljati krvne preiskave, še posebej tiste, s katerimi bo v primeru slabega delovanja ledvic spremljal vrednosti kalija v krvi.
In this case your doctor will want to monitor you more closely.
V tem primeru vas bo zdravnik hotel bolj natančno spremljati;
In this case, a dose of 2.5 mg daily must not be exceeded (see sections 4.4 and 5.2).
V takem primeru se ne sme prekoračiti odmerka 2,5 mg na dan (glejte poglavji 4.4 in 5.2).
In this case, anaesthesia and surgery must be postponed for at least 2 hours, if possible.
V takem primeru je treba anestezijo in kirurški poseg prestaviti za vsaj dve uri, če je mogoče.
In this case, do not use the product.
V tem primeru zdravila ne uporabite.
In this case, glycerol phenylbutyrate will not stop the level of ammonia in your blood from becoming seriously high.
V tem primeru zdravilo Ravicti ne bo preprečilo prekomernega zvišanja ravni amoniaka v krvi.
In this case, it is advisable to rehydrate patients first and then start therapy with Dynastat.
Te bolnike je priporočljivo najprej rehidrirati in šele potem začeti zdravljenje z zdravilom Dynastat.
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.
V teh primerih bo nadzoroval ledvično delovanje v določenih časovnih presladkih.
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.
V teh primerih bo vaš zdravnik nadzoroval ledvično delovanje v določenih časovnihpresledkih.
In this case, patients should be monitored for liver impairment.
V tem primeru je treba bolnike spremljati glede jetrne okvare.
In this case, please see below: “
V tem primeru glejte spodnje besedilo z naslovom: „
In this case, roflumilast treatment should be reassessed (see section 4.4).
V takšnih primerih je treba zdravljenje z roflumilastom ponovno ovrednotiti (glejte poglavje 4.4).
In this case, the decision to give any further vaccine containing tetanus toxoid should be evaluated by your doctor. is having a treatment that suppresses her/his immune system (the body’s natural defenses) or has any disease that causes the weakness of the immune system.
V tem primeru mora odločitev o nadaljnjem dajanju cepiva, ki vsebuje tetanusni toksoid, pretehtati zdravnik. bil zdravljen z zdravilom, ki zavira njegov/njen imunski sistem (naravni obrambni mehanizem telesa), ali ima otrok katerokoli bolezen, ki povzroča šibkost imunskega sistema.
In this case, the follitropin alfa dose is usually increased every 7 or every 14 days by 37.5 to 75 IU.
V tem primeru se odmerek zdravila folitropin alfa navadno poveča vsakih 7 ali vsakih 14 dni za 37,5 do 75 i.e.
In this case, the Insulin Release Unit (IRU) must be changed prior to the next inhalation (see section 4.4).
V takšnem primeru je treba nastavek za sproščanje insulina (Insulin release unit - IRU) pred naslednjo inhalacijo zamenjati (glejte poglavje 4.4).
In this case, the Insulin Release Unit (IRU) must be changed prior to the next inhalation (see section 6.6).
V takšnem primeru je treba nastavek za sproščanje insulina (Insulin release unit - IRU) pred naslednjo inhalacijo zamenjati (glejte poglavje 6.6).
In this case, the product expires at the end of this 12-month period or the expiration date on the product vial, whichever is earlier.
V tem primeru rok uporabnosti zdravila poteče ob koncu 12-mesečnega obdobja ali z datumom izteka roka uporabnosti navedenega na viali zdravila, odvisno kateri je prej.
In this case, the product expires at the end of this 12-month period or the expiry date on the product vial, whichever is earlier.
V tem primeru se rok uporabnosti zdravila izteče ob koncu 12- mesečnega obdobja ali z datumom izteka roka uporabnosti navedenega na viali zdravila, odvisno kaj nastopi prej.
In this case, the vaccine may not work very well.
V teh primerih se lahko zgodi, da cepivo ne bo delovalo najbolje.
In this case, treatment should be stopped.
Če pride do oslabitve sluha, je treba prekiniti zdravljenje.
In this case, you should avoid any activity that requires mental alertness such as driving a car or using any machine.
V tem primeru se morate izogibati vsem aktivnostim, ki zahtevajo vašo pozornost, kot je na primer vožnja ali upravljanje s stroji.
In this case, you will have to take the tablets only once or twice a day.
Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali ali pa boste morda začeli jemati katero zdravilo.
In this case, your child’s blood potassium level should be measured.
V tem primeru je treba otroku meriti raven kalija v krvi.
In this case, your doctor will prescribe you Adempas at the highest dose you are comfortable on.
V tem primeru vam bo zdravnik predpisal največji odmerek zdravila Adempas, ki je za vas primeren.
In this cases Oprymea may effect your ability to drive and operate machinery.
V teh primerih zdravilo Oprymea lahko zmanjša vašo sposobnost za vožnjo ali upravljanje strojev.
In this category of animals the vaccine should be used only according to the benefit-risk assessment by the responsible veterinarian and/or National Competent Authorities on the current vaccination policies against bluetongue virus (BTV).
Pri tej kategoriji živali je treba cepivo uporabljati glede na presojo odgovornega veterinarja glede razmerja korist-tveganje oziroma v skladu z veljavnimi smernicami pristojnih Nacionalnih organov glede cepljenja proti bolezni modrikastega jezika (BTV).
In this category of animals the vaccine should be used only according to the benefit-risk assessment by the responsible veterinarian and/or National Competent Authorities on the current vaccination policies against bluetongue virus (BTV).
Pri tej kategoriji živali je treba cepivo uporabljati glede na presojo odgovornega veterinarja glede razmerja korist/tveganje oziroma v skladu z veljavnimi smernicami pristojnih nacionalnih organov glede cepljenja proti bolezni modrikastegajezika (BTV).
In this category of animals the vaccine should be used only according to the benefit-risk assessment by the responsible veterinarian and/or National competent authorities on the current vaccination policies against bluetongue virus (BTV).
Pri tej kategoriji živali lahko cepivo uporabimo le na podlagi ocene razmerja med koristmi in tveganji, ki jo pripravijo odgovorni veterinar in/ali pristojni nacionalni organi, odvisno od veljavne politike cepljenja proti virusu bolezni modrikastega jezika (BTV).
In this category of animals the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against Bluetongue virus (BTV).
Pri tej kategoriji živali cepivo uporabite le v skladu z oceno razmerja korist/tveganje odgovornega veterinarja in/ali v skladu z veljavnimi smernicami pristojnih nacionalnih organov glede cepljenja proti bolezni modrega jezika (BTV).
In this category of animals the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against BTV.
Pri tej kategoriji živali cepivo uporabite le v skladu z oceno razmerja korist/tveganje odgovornega veterinarja in/ali v skladu z veljavnimi smernicami pristojnih nacionalnih organov glede cepljenja proti bolezni modrega jezika (BTV).
In this category of animals, the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against Bluetongue Virus (BTV).
Pri tej kategoriji živali cepivo uporabite le v skladu z oceno razmerja korist/tveganje odgovornega veterinarja in/ali v skladu z veljavnimi smernicami pristojnih nacionalnih organov glede cepljenja proti bolezni modrega jezika (BTV).